Estevez-Fraga, Carlos;
Tabrizi, Sarah J;
Wild, Edward J;
(2023)
Huntington's Disease Clinical Trials Corner: July 2023.
Journal of Huntington's Disease
pp. 1-17.
10.3233/JHD-239001.
(In press).
Preview |
PDF
jhd-prepress_jhd--1--1-jhd239001_jhd--1-jhd239001.pdf - Published Version Download (106kB) | Preview |
Abstract
In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington's disease.
| Type: | Article |
|---|---|
| Title: | Huntington's Disease Clinical Trials Corner: July 2023 |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3233/JHD-239001 |
| Publisher version: | https://doi.org/10.3233/JHD-239001 |
| Language: | English |
| Additional information: | © 2023 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/). |
| Keywords: | Huntington disease, clinical trials |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10174142 |
Archive Staff Only
 |
View Item |
